Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oxygen Healthcare (O2h) has agreed to add significant number of FTE chemists at Heptares' discovery programmes by expanding their existing chemistry collaboration.
Subscribe to our email newsletter
O2h offers synthetic chemistry, FTE-based medicinal and process chemistry including in-vitro biology services to pharmaceutical and biotechnology companies.
Heptares Chemistry head Miles Congreve said O2h has been a valuable partner for the company and they are happy to further extend their synthetic chemistry team to include a full lab unit at O2h.
O2h CEO Sunil Shah said this is a new milestone in their on-going relationship with Heptares and they are excited to support them on their journey.